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Vincent and colleagues discussed some of the key issues
related to antibiotic management in the critically ill, in-
cluding problems associated with timing, duration, and
dosing of antibiotics [1]. In particular, the authors
highlighted the importance of early diagnosis of infec-
tion and controversies about the use of combination or
monotherapy and the duration of therapy [1]. We agree
that decisions regarding the use of antibiotics should be
made on an individual basis, e.g., according to the sever-
ity of the disease and local microbiological patterns [1].
However, some issues should be taken into account in
determining an antibiotic therapy.
Vincent et al.’s review covered all infections in the crit-
ically ill but, with regard to the duration of antibiotic
treatment, the authors referred to a guideline for the
management of sepsis and septic shock only [2]. Dichot-
omy according to nosocomial or community-acquired
infection seems necessary to make better decisions.
Moreover, severe nosocomial infections like sepsis due
to resistant Gram-negative bacteria and mild infections
like community-acquired pneumonia caused by a sus-
ceptible microorganism may need different guidelines.
Non-intensive care unit-acquired pneumonia has re-
cently been proposed as a new clinical entity, as epi-
demiological data seem to be different between patients
acquiring hospital-acquired pneumonia in the intensive
care unit versus general wards [3].
Among others, the consciousness state of the critically
ill seems important for the initiation or discontinu-
ation of antibiotic treatment. Ventilator-associated
pneumonia is the most frequent intensive care unit-
related infection in patients requiring mechanical ven-
tilation, and comatose patients present a high risk of
early-onset ventilator-associated pneumonia [4]. For
comatose patients who required mechanical ventila-
tion, antibiotic prophylaxis at intubation lowers the
incidence of ventilator-associated pneumonia [4]. In
patients with ventilator-associated pneumonia due to
non-fermenting Gram-negative bacilli, there appears to be
a higher risk of recurrence following short-course therapy,
i.e., a 7–8-day course [5].
Doctors in Western countries may say that it takes
seven days to cure a common cold with medication but
it will take a week to get better without it, but this ad-
vice does not apply to developing countries like China.
Subsequent bacterial infections may prolong a common
cold to as long as one month. The use of antibiotics var-
ies substantially, even among developed countries. This
discrepancy is particularly important for pediatric pa-
tients and the elderly with poor health. In conclusion,
for antibiotic medication, general recommendations
should be tempered by awareness of many local and
specific factors in order to get the best effect from
medicines.
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We thank Drs Jia and Jia for their interest in our recent
review on antibiotic therapy [1]. Indeed, as mentioned
briefly in our concluding paragraph, it is obvious that
optimal antibiotic therapy—in terms of choice of anti-
biotic, dose, and duration of therapy—in critically ill pa-
tients will be influenced by multiple factors. Examples
include the past history and age of the patient, the
site and severity of infection, any previous prolonged
exposure to antibiotics, likely causative organisms,
concomitant therapies such as renal support, and
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local microbiological patterns, including bacterial re-
sistance. Another important issue is the immune sta-
tus of these patients [6]. Sepsis may significantly and
rapidly alter cellular and humoral immune responses,
such that hospital-acquired (and recurrent) infections
may be secondary to a marked immunosuppressed
state, which, together with insufficient tissue drug
penetrations and high resistance levels, may further
limit the definition of “adequate” antibiotic therapy
and clinical response in this setting.
Drs Jia and Jia also mention that antibiotic “prophy-
laxis” may reduce the occurrence of ventilator-
associated pneumonia in brain-injured patients [4].
Nevertheless, this strategy had no impact on survival
or hospital stay and needs to be further evaluated in
prospective studies before it can be considered as
“standard of care”.
Regarding the last statement on the use of antibi-
otics in patients with a common cold in developing
countries, we respectfully disagree. Recommendations
to rationalize the use of antibiotics in patients with
acute respiratory infections have the common objective of
minimizing unnecessary antibiotics because “antibiotic
pressure” is one of the factors triggering bacterial resist-
ance. Antibiotics are widely misused in medicine, espe-
cially for viral infections. Should subsequent bacterial
infection develop, appropriate targeted antibiotics should
then be started.
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